InvestorsHub Logo
Followers 29
Posts 2647
Boards Moderated 0
Alias Born 07/26/2016

Re: govorchin post# 363300

Tuesday, 06/22/2021 2:35:04 PM

Tuesday, June 22, 2021 2:35:04 PM

Post# of 402865
I check the website every week or two and see that 3 products are in clinical development. AlfaSigma has two Crohn's studies on the government's clinical study site, but no mention of Brilacidin. When I used other study terms I came up with this:

Recruiting A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis
Ulcerative Colitis
Ulcerative Proctitis
Ulcerative Proctosigmoiditis
Drug: Niclosamide
Fondazione IRCCS Policlinico San Matteo - Phase I Clinical Trial Unit And Experimental Therapy
Pavia, Italy
U.O.C. Gastroenterologia ed Endoscopia Digestiva - Azienda Ospedaliera Universitaria PTV - Policlinico
Roma, Italy
Centro Ricerche Cliniche di Verona
Verona, Italy

But this test is of Niclosamide, not Brilacidin, so maybe it is the third test referred to, and Brilacidin has not yet been listed. Brilacidin was mentioned in summary literature last year, but I can no longer find that mention, though it still may be there. A more adept researcher may find more than I did.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News